Gb Sciences, Inc

Gb Sciences, Inc company information, Employees & Contact Information

Explore related pages

Related company profiles:

GB Sciences, Inc. (OTCQB:GBLX) is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform plant-inspired drug development targeting novel treatments for multi-billion dollar biopharma markets. GB Sciences’ proprietary Generative-AI Powered Drug Discovery Platform (PhAROS™) predicts novel, simple, plant-based mixtures to address multi-billion-dollar markets. PhAROS™ leverages demonstrated healing from within 12 global Traditional Medical Systems (TMS); pre-validates novel, simple, plant-based mixtures to address multi-billion-dollar markets; and goes beyond looking at what has worked within plant-based medicines in the past to predicting the efficacies of entirely new formulations that have not existed anywhere. GbS’ new proprietary mixtures often include components from different plants growing on different continents in different TMS that may never have been used together before. GB Sciences’ novel AI-powered drug discovery platform has yielded 8 US & 14 global patents that are issued and protect 28 unique formulas for human health disorders. Additionally, GbS has 15 US and 41 global patents-pending that cover 25 unique formulas for human health disorders. GbS has 5 late preclinical programs with cell & animal data supporting novel treatments of Parkinson’s disease, chronic pain, stress & anxiety, cytokine syndromes, and heart failure. Our lead Parkinson’s disease therapeutic program is being prepared for a First-in-Man clinical trial. GbS' productive research and development network includes industry leading biopharmaceutical CMOs and service providers, nine universities, several hospitals, and global clinical CROs.

Company Details

Employees
22
Address
6450 Cameron St #110, Las Vegas,nevada 89118,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
providers.
HQ
Las Vegas, Nevada
Looking for a particular Gb Sciences, Inc employee's phone or email?

Gb Sciences, Inc Questions

News

GB Sciences Receives $4,150,000 and Completes the Sale of Its Louisiana Operations to Wellcana Plus - ACCESS Newswire

GB Sciences Receives $4,150,000 and Completes the Sale of Its Louisiana Operations to Wellcana Plus ACCESS Newswire

GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-in-Human Trial for Their Cannabinoid-Based Parkinson’s Drug - Newswire.com

GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-in-Human Trial for Their Cannabinoid-Based Parkinson’s Drug Newswire.com

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences - Yahoo Finance

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences Yahoo Finance

GB Sciences, Inc. Announces The Appointment Of Mr. Leslie Bocskor As Vice Chairman - PR Newswire

GB Sciences, Inc. Announces The Appointment Of Mr. Leslie Bocskor As Vice Chairman PR Newswire

Gary Herman Joins GB Sciences' Subsidiary GbS Global Biopharma as Advisory Director - PharmiWeb.com

Gary Herman Joins GB Sciences' Subsidiary GbS Global Biopharma as Advisory Director PharmiWeb.com

More From Meredith Patterson, GB Sciences’ Brain Nurse, As She Examines the Workings of CBD - MultiVu

More From Meredith Patterson, GB Sciences’ Brain Nurse, As She Examines the Workings of CBD MultiVu

Check out GB Sciences's stock price (GBLX) in real time - CNBC

Check out GB Sciences's stock price (GBLX) in real time CNBC

GB Sciences completes $16M deal with Lafayette company for LSU medical marijuana operation - The Advocate

GB Sciences completes $16M deal with Lafayette company for LSU medical marijuana operation The Advocate

GB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits - PR Newswire

GB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits PR Newswire

GB Sciences and Louisiana State University Agricultural Center Begins Cultivation of Their First Cannabis Crop - MultiVu

GB Sciences and Louisiana State University Agricultural Center Begins Cultivation of Their First Cannabis Crop MultiVu

GrowBLOX Sciences Appoints New CFO John Poss - ACCESS Newswire

GrowBLOX Sciences Appoints New CFO John Poss ACCESS Newswire

Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform - Newswire.com

Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform Newswire.com

GB Sciences selling remaining 50% stake in Louisiana medical marijuana business to Lafayette company for $16 million - The Advocate

GB Sciences selling remaining 50% stake in Louisiana medical marijuana business to Lafayette company for $16 million The Advocate

GrowBLOX Sciences Executes Cannabis Supply Agreement with Provisionally Licensed Medical Cannabis Dispensary Facility - ACCESS Newswire

GrowBLOX Sciences Executes Cannabis Supply Agreement with Provisionally Licensed Medical Cannabis Dispensary Facility ACCESS Newswire

TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference - Newswire.com

TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference Newswire.com

GB Sciences Using AI Technology in Plant-Based Drug Discovery Research - Newswire.com

GB Sciences Using AI Technology in Plant-Based Drug Discovery Research Newswire.com

Gb Sciences is Leading Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS - Newswire.com

Gb Sciences is Leading Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS Newswire.com

Gb Sciences Accelerates Drug Development via Innovative Biopharma Technology and Strategic Partnerships - Newswire.com

Gb Sciences Accelerates Drug Development via Innovative Biopharma Technology and Strategic Partnerships Newswire.com

Top Gb Sciences, Inc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant